Published by Josh White on 10th November 2022
(Sharecast News) - Biopharmaceuticals developer Arecor Therapeutics has signed an exclusive formulation study collaboration with the pharmaceutical division of "one of the world's largest" chemicals marketing and pharma companies, it announced on Thursday, which focuses on the development and commercialisation of speciality drugs.